Description

Bromopride is a potent substituted benzamide derivative with significant pharmacological activity. This compound is a critical intermediate in the synthesis of advanced pharmaceutical agents, valued for its specific chemical structure and functionality. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of gastrointestinal motility regulators and antiemetic drugs. Bromopride CAS NO 4093-35-0 represents a high-purity building block essential for producing consistent and effective final drug products.

Application

• Pharmaceutical Intermediate: Key starting material or intermediate in the synthesis of prescription drugs targeting gastrointestinal disorders.
• Research & Development: Used in biochemical and pharmacological research to study dopaminergic and gastroprokinetic pathways.
• Reference Standard: Serves as a high-purity analytical standard for quality control and method validation in pharmaceutical laboratories.
• Active Pharmaceutical Ingredient (API) Synthesis: Employed in the multi-step synthesis of the final API for antiemetic and prokinetic medications.
• Metabolite Studies: Utilized in the development and analysis of drug metabolites for pharmacokinetic profiling.

Basic Information

Product Name	Bromopride
CAS No.	4093-35-0
Molecular Formula	C14H22BrN3O3
Molecular Weight	360.25 g/mol
Synonyms	4-Amino-5-bromo-N-[(2-diethylamino)ethyl]-2-methoxybenzamide; BRL 20627; 5-Bromo-2-methoxy-4-aminobenzoic acid diethylaminoethylamide; Bromopridum; Bromoprid; (4-Amino-5-bromo-2-methoxyphenyl)(4-(diethylamino)-1-oxobutan-2-yl)methanone
EINECS	223-849-3

Quality Control

Our Bromopride is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot is subjected to comprehensive analytical testing, including identification, assay, and impurity profiling via HPLC and other validated methods. We provide full traceability and support our customers with detailed Certificates of Analysis (COA) that confirm compliance with agreed specifications. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and must be kept under dry conditions to prevent degradation. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.5%
Related Substances (HPLC)	Total impurities ≤ 1.0% Any single impurity ≤ 0.5%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.